Use of PHY906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome Grant US-11452755-B2 United States of America 27 Sep 2022
Use of compounds that are able to increase the serum IGF-1 level for the preparation of a… Grant US-10716778-B2 United States of America 21 Jul 2020
Use of PHY906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome Grant US-10058581-B2 United States of America 28 Aug 2018
USE OF PHY906 AS TREATMENT FOR INFLAMMATORY BOWEL DISEASE AND/OR IRRITABLE BOWEL SYNDROME Application EP-2987495-A1 European Patent Office 24 Feb 2016